PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
26-Sep-2022 AlivaMab Discovery Services Reappoints Dr. Larry Green as Chief Executive Officer AlivaMab Discovery Services
26-Sep-2022 Immunotherapy: Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532  Andrew Lloyd Associates
26-Sep-2022 Immunotherapy: Tollys presents new data at OTS 2022, demonstrating anti-tumor activity of TL-532  Andrew Lloyd Associates
26-Sep-2022 TolerogenixX Publishes Three-Year Follow-Up Data from Phase I Trial of Immune Tolerance-Inducing MIC-Lx Cell Therapy TolerogeniXx GmbH
23-Sep-2022 Envision Pharma Group appoints new CEO Envision Pharma Group
23-Sep-2022 Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation Creative Enzymes
23-Sep-2022 Creative Enzymes Announces the Launch of Kex2 Protease from Saccharomyces Cerevisiae, Recombinant Creative Enzymes
22-Sep-2022 Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals Creative Proteomics
22-Sep-2022 Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins Creative Proteomics
21-Sep-2022 QuBAS 3.0 cuts biostatistics method development time by 80% Quantics Biostatistics
21-Sep-2022 Tower to bring the temperature of pharmaceutical logistics to CPhI Tower Cold Chain
21-Sep-2022 Inizio Biotech makes key leadership appointment to meet demand from emerging biotech Inizio Biotech
21-Sep-2022 World-class translational project enters BioInnovation Institute’s Bio Studio program as part of collaboration with Imperial College London BioInnovation Institute (BII)
20-Sep-2022 RNA Delivery and Therapeutics Company SiSaf Announces Autumn Conference Schedule SiSaf Ltd
20-Sep-2022 Coave Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference Coave Therapeutics
20-Sep-2022 Tiziana Life Sciences Announces Continued Clinical Improvements in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) After Six Months of Dosing with Intranasal Foralumab Tiziana Life Sciences
20-Sep-2022 Genomic data start-up opens global headquarters Zetta Genomics
20-Sep-2022 GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Process GenScript
20-Sep-2022 Synaffix Wins ‘Best ADC Platform Technology’ Award Again at World ADC Awards Ceremony 2022 Synaffix
20-Sep-2022 Immutep Clinical Development Update for its First-in-Class LAG-3 Antigen Presenting Cell Activator Candidate Eftilagimod Alpha Immutep